Skip to main content

The Wistar Institute

|

Combining Expertise, The Wistar Institute and Batavia Biosciences Partner to Expand Rubella Vaccine Manufacturing Around the World 

Companies that make rubella vaccines have been getting harder and harder to come by. The global production of the rubella vaccine, supplied in combination with measles, mumps and varicella vaccines, which is the typical route for…
Read more
|

Wistar and Penn Medicine Awarded $11.7 Million Melanoma Research Grant from the National Cancer Institute

PHILADELPHIA — (Sept. 22, 2021) —The Wistar Institute and Penn Medicine have been awarded a prestigious $11.7 million Specialized Programs of Research Excellence, or SPORE, grant from the National Cancer Institute. The five-year award will fund thre…
Read more
|

Wistar Scientists Identify New Therapeutic Target in Ovarian Cancer Subtype With Poor Prognosis

PHILADELPHIA — (Sept. 21, 2021) — Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A functi…
Read more
|

Dr. Noam Auslander: New Faculty Addition Brings Artificial Intelligence Research to Wistar

Wistar welcomes Dr. Noam Auslander as an assistant professor in the Cancer Center’s Molecular & Cellular Oncogenesis Program. She applies artificial intelligence (AI) through high-throughput computer approaches to interpret the very large sets o…
Read more
|

Dr. Hildegund Ertl: Vaccine Thought Leader and Formidable Presence

Dr. Hildegund Ertl, Wistar immunologist and vaccine developer, has been featured in local and national media and sought after by journalists as a source of expert opinions. A well-spoken scientist, always available to help unravel the many questions…
Read more
|

Bringing Together Cutting Edge Technologies, Daniel Claiborne, Ph.D., Charts a Course for Solving Puzzles About HIV Infection

Mice differ from people in many ways. But over the last decade, scientists have succeeded in engineering mice that are more humanlike in their ability to be infected with HIV, making it possible to study the disease, and develop vaccines and therapi…
Read more
|

Cheyney University Students Kick Off Their Biomedical Research Journey at Wistar

Last February, Wistar welcomed the inaugural group of Cheyney University students enrolled in the biomedical research and training program co-developed in 2020 by the nation’s first biomedical research institute and the nation’s first historically b…
Read more
|

Motivated By the Hard Questions in Cancer Research, Noam Auslander, Ph.D., Forges New Paths in Computational Biology

Many people unwind in front of the television after a long day. But Noam Auslander, Ph.D., who joined The Wistar Institute Cancer Center in June as an assistant professor, often spends the evening glued to the screen of her MacBook Pro laptop instea…
Read more
|

Studying Immunology and Cancer, Nan Zhang, Ph.D., Delves Into Mysteries Of Ovarian Cancer Metastasis

Few biologists can say they saw a type of cells for the first time. Nan Zhang, Ph.D., who started at The Wistar Institute in September as an assistant professor, became one of those biologists when, during his postdoctoral research at Washington Uni…
Read more
|

Destined for Science, Amelia Escolano, Ph.D., Develops New Vaccination Strategies to Outsmart HIV-1, and Other Highly Mutating Pathogens

Scientists developed COVID-19 vaccines in record time — less than a year after the genome of the virus was sequenced, countries started authorizing use of multiple vaccines. But the virus is rapidly changing, and new variants have been emerging that…
Read more